Literature DB >> 198487

Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.

J A Zaia, M N Oxman.   

Abstract

A sensitive and reproducible technique was developed for the detection of antibody to varicella-zoster virus-induced membrane antigen (VZMA) by immunofluorescence. Controlled trypsinization and glutaraldehyde fixation were employed to prepare a monodisperse suspension of noninfectious VZMA-positive target cells that can be stored indefinitely at -72 degrees C. A microtiter immunofluorescence assay utilizing these target cells was shown to provide a sensitive and specific means for the detection and quantitation of antibody to varicella-zoster virus. The properties of the target cell preparation and the characteristics of the assay make practical the rapid assessment of immunity to the varicella-zoster virus.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 198487     DOI： 10.1093/infdis/136.4.519

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  39 in total

1.  Antibody to varicella-zoster virus after passive immunization against chickenpox.

Authors:  A A Gershon; S Piomelli; M Karpatkin; E Smithwick; S Steinberg
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

2.  Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.

Authors:  B Forghani; N J Schmidt; J Dennis
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

3.  Processing and presentation of cell-associated varicella-zoster virus antigens by human monocytes.

Authors:  O Pontesilli; P Carotenuto; M J Levin; D Suez; A R Hayward
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

4.  Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus.

Authors:  M L Landry; S D Cohen; D R Mayo; C K Fong; W A Andiman
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

5.  Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test.

Authors:  P Larussa; S Steinberg; E Waithe; B Hanna; R Holzman
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

6.  Immunofluorescence for detection of antibodies against human cytomegalovirus-induced membrane antigens.

Authors:  J M Middeldorp; J Jongsma; T H The
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

7.  Sensitive solid-phase radioimmunoassay for detection of human immunoglobulin G antibodies to varicella-zoster virus.

Authors:  M G Friedman; S Leventon-Kriss; I Sarov
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

8.  Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

Review 9.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

10.  Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay.

Authors:  Jeffrey I Cohen; Mir A Ali; Ahmad Bayat; Sharon P Steinberg; Hosun Park; Anne A Gershon; Peter D Burbelo
Journal:  Clin Vaccine Immunol       Date:  2014-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.